Delivery Order SPE2DB20D2014-SPE2DB25FC53R
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $14,452.05 by the Defense Logistics Agency on September 15, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract utilizes firm fixed price pricing and is scheduled for completion by October 6, 2025. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $3,853.88 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 ml vials on September 10, 2025, with an ultimate completion date of October 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $14,452.05 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $4,817.35 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for AVEED 750 mg/3 mL vials. This competitively awarded contract, with an ultimate completion date of August 27, 2025, represents a firm fixed-price transaction with no set-aside designation. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract, valued at $23,123.28, carries a firm fixed price and requires completion by June 23, 2025. This is a non-set-aside delivery order issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide AVEED 750 MG/3 ML VIAL 3ML pharmaceutical products. The $7,765.20 contract has an ultimate completion date of April 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AVEED 750 MG/3 ML VIAL 3ML medical products. The contract, valued at $8,033.50, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the medication AVEED 750 MG/3 ML VIAL 3ML, and has a ceiling value of $31,216.80. The award has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are for-profit...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract is a firm fixed price contract with a ceiling value of $38,826.00 and a period of performance through September 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,213.40 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC53RDelivery Order
The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M and extending through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard through flexible and competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 7/22/25 |